Top Markets
Coin of the day
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
Kedudukan dalam Saham #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Harga Saham
$14.66
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$839.37M
Perubahan (1 hari)
-2.67%
Perubahan (1 tahun)
557.32%
Negara
US
Perdagangan Climb Bio, Inc. (CLYM)

Kategori

Sejarah pecahan saham untuk Climb Bio, Inc. (CLYM)
Saham Climb Bio, Inc. (simbol: CLYM) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 30, 2026.
Satu saham CLYM yang dibeli sebelum Aug 30, 2026 kini bersamaan dengan 0 saham CLYM.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH